Lexaria Bioscience Corp Live Stock Price Today, Share Analysis and Chart

Name: Lexaria Bioscience Corp: Is Infosys Ltd. worth buying?
Item: Lexaria Bioscience Corp
Rating: 1.10691675
Author: Trendlyne DVM scores

about

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability...

0.82 0.02 (2.50%)

59.61% Fall from 52W High

317.2K

XNAS Volume

XNAS 22 Jan, 2026 4:19 PM (EST)

Board Meeting

The next board meeting for Lexaria Bioscience Corp is on 27 Jan 2026 for the purpose of Lexaria Bioscience Corp Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

8.2 / 100

Technically Neutral

36.1 / 100

1Yr Price target upside is 449%

3 analysts

Lexaria Bioscience Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lexaria Bioscience Corp Live Stock Price Today, Share Analysis and Chart

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability...

59.61% Fall from 52W High

SWOT Analysis

Lexaria Bioscience Corp Live Price Chart